berberine has been researched along with clarithromycin in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Feng, PF; Guo, F; Li, BX; Sun, JL; Zhang, R; Zhao, X; Zhi, D | 1 |
| Chen, Y; Ke, L; Li, CJ; Liang, J; Ni, Z; Shang, L; Shi, YQ; Zhang, D; Zhang, LH; Zhu, SH | 1 |
| Aceña, LE; Coolen, JPM; Jansen, RS; Koenderink, JB; Ruesen, C; Schildkraut, JA; Te Brake, LHM; van den Heuvel, JJMW; van Ingen, J; Wertheim, HFL | 1 |
| Chen, S; Dong, Q; Liu, Y; Shen, W; Shi, Y | 1 |
2 trial(s) available for berberine and clarithromycin
| Article | Year |
|---|---|
Berberine containing quadruple therapy for initial Helicobacter pylori eradication: An open-label randomized phase IV trial.
Topics: Adult; Age Factors; Amoxicillin; Antacids; Anti-Bacterial Agents; Berberine; Bismuth; Body Mass Index; Breath Tests; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Proton Pump Inhibitors; Severity of Illness Index; Sex Factors | 2017 |
Efficacy and safety of triple therapy containing berberine, amoxicillin, and vonoprazan for Helicobacter pylori initial treatment: A randomized controlled trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Berberine; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Rabeprazole; Treatment Outcome | 2023 |
3 other study(ies) available for berberine and clarithromycin
| Article | Year |
|---|---|
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
The enhancement of cardiac toxicity by concomitant administration of Berberine and macrolides.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Berberine; Clarithromycin; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Synergism; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Heart Diseases; HEK293 Cells; Humans; Male; Membrane Potentials; Microsomes, Liver; Myocytes, Cardiac; Potassium Channel Blockers; Rats; Rats, Wistar; Risk Assessment; Transfection | 2015 |
The potential role of drug transporters and amikacin modifying enzymes in M. avium.
Topics: Amikacin; Anti-Bacterial Agents; ATP-Binding Cassette Transporters; Berberine; Clarithromycin; Ethambutol; Humans; Membrane Transport Proteins; Mycobacterium avium; Mycobacterium avium Complex; Mycobacterium tuberculosis | 2023 |